Showing posts with the label AdcentrxShow all
Technology
Adcentrx Therapeutics to Present Preclinical Data for Nectin-4 ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024
Preclinical data support clear differentiation of Adcentrx's platform and lead program, ADRX-0706, currently being evaluated in a Phase 1a/b clin…
Read more
Trend Insights News is your go-to source for timely, insightful, and impactful news coverage. We bring you the stories that matter — from global headlines to emerging trends — with clarity, depth, and integrity.
Social Plugin